Both in Pharmaceuticals
Pacira BioSciences vs Phibro Animal Health
Over the past year PCRX returned +60.1% and PAHC returned +0.8%; their daily moves had a correlation of 0.08.
PCRX +60.1% PAHC +0.8%Growth of $1, one year, split-adjusted
| Metric | PCRX | PAHC |
|---|---|---|
| Price | $36.40 | $37.93 |
| Market cap | $1.45B | $1.54B |
| Today | +0.25% | +3.04% |
| 1 month | +51.2% | +8.3% |
| 6 months | +55.4% | −31.0% |
| Year to date | +40.6% | +1.5% |
| 1 year | +63.5% | +3.7% |
| Revenue growth (YoY) | +6.2% | +4.8% |
| Gross margin | 77.0% | 33.9% |
| Net margin | 2.4% | 5.5% |
| P/E (TTM) | 99.2× | 15.4× |
| Price / sales | 1.9× | 1.0× |
| Net cash | -$112.1M | -$650.8M |
| Dividend yield | — | 1.27% |
| Volatility (60d) | 82.8% | 31.0% |
| Short % of float | 21.2% | 4.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).